Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4843458

COc1ccccc1-c1nc2cc(Br)cnc2[nH]1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.43
SLC9A1 P19634 1/20 0.41
AMY1A P0DUB6 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GUSB P08236 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
PARP1 P09874 1/20 0.40
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
FGFR1 P11362 1/20 0.39
FGFR2 P21802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13607761 0.89 PDE5A (0.52) PDE5AAMY1ACSNK2A2CSNK2BCCNB2
Trifluoroacetic Acid SCHEMBL4841890 0.86 PTGES (0.46) SLC9A1HDAC6FGFR2
SCHEMBL4844661 0.85 PDE5A (0.37) PDE5AGUSBHDAC6CDK1CDK5
Trifluoroacetic Acid SCHEMBL4844656 0.85 PTGES (0.47) PDE5AGUSBHDAC6CCNB2CDK1
Trifluoroacetic Acid SCHEMBL4842876 0.81 CHEK2 (0.45) GUSBPARP1
Trifluoroacetic Acid SCHEMBL4844143 0.81 ABL1 (0.49) HDAC6TAAR1
Trifluoroacetic Acid SCHEMBL5262965 0.80 PIN1 (0.51) SLC9A1HDAC6PARP1AURKA
Trifluoroacetic Acid SCHEMBL4844050 0.80 PDE4A (0.53) AMY1AGUSBHDAC6
Trifluoroacetic Acid SCHEMBL4840500 0.78 BRD4 (0.42) HDAC6PARP1TAAR1
SCHEMBL709150 0.78 GCK (0.41) PDE5AGUSBCDK1CDK5FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 PDE5A 908/4885SLC9A1 3790/4885AMY1A 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.